Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Marsh

Showing results (81-90 of 337) with videos related to

Pageof 34
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 23, 2005
Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?Alexis Nzila, Edwin Ochong, Eunice Nduati, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparumSheila Ommeh, Eunice Nduati, Eddy Mberu, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 18, 2014
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaJohn Okombo, Alice W Kamau, Kevin Marsh, et al.
The Journal of Infectious Diseases|August 19, 2011
The plasma concentration of the B cell activating factor is increased in children with acute malariaEunice Nduati, Agnes Gwela, Henry Karanja, et al.
Nature|June 4, 2004
Transient cross-reactive immune responses can orchestrate antigenic variation in malariaMario Recker, Sean Nee, Peter C Bull, et al.
Advances in Therapy|November 30, 2022
Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney DiseaseAna Filipa Alexandre, Antonia Morga, Caitlin Thomas, et al.
The Patient|May 19, 2021
Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A NephropathyKevin Marsh, Kerrie-Anne Ho, Rachel Lo, et al.
Infection and Immunity|April 18, 2007
Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolatesAnne-Marie Deans, Susana Nery, David J Conway, et al.
Malaria Journal|June 30, 2009
Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolatesJane E Blythe, Makhtar Niang, Kevin Marsh, et al.
Wellcome Open Research|June 7, 2019
A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 <sub>E</sub> on blood stage immunity in young Kenyan childrenFrancis M Ndungu, Jedida Mwacharo, Juliana Wambua, et al.
Pageof 34

Showing results (81-90 of 337) with videos related to

Sort By:
Pageof 34
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 23, 2005
Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?Alexis Nzila, Edwin Ochong, Eunice Nduati, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparumSheila Ommeh, Eunice Nduati, Eddy Mberu, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 18, 2014
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaJohn Okombo, Alice W Kamau, Kevin Marsh, et al.
The Journal of Infectious Diseases|August 19, 2011
The plasma concentration of the B cell activating factor is increased in children with acute malariaEunice Nduati, Agnes Gwela, Henry Karanja, et al.
Nature|June 4, 2004
Transient cross-reactive immune responses can orchestrate antigenic variation in malariaMario Recker, Sean Nee, Peter C Bull, et al.
Advances in Therapy|November 30, 2022
Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney DiseaseAna Filipa Alexandre, Antonia Morga, Caitlin Thomas, et al.
The Patient|May 19, 2021
Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A NephropathyKevin Marsh, Kerrie-Anne Ho, Rachel Lo, et al.
Infection and Immunity|April 18, 2007
Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolatesAnne-Marie Deans, Susana Nery, David J Conway, et al.
Malaria Journal|June 30, 2009
Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolatesJane E Blythe, Makhtar Niang, Kevin Marsh, et al.
Wellcome Open Research|June 7, 2019
A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 <sub>E</sub> on blood stage immunity in young Kenyan childrenFrancis M Ndungu, Jedida Mwacharo, Juliana Wambua, et al.
Pageof 34